Biosergen AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	15.37	50.61	1.88	29.34	21.67
Cash & Short-Term Investments	15.37	50.61	1.88	29.34	21.67
Cash Growth	-69.64%	2587.84%	-93.58%	35.44%	3578.27%
Accounts Receivable	-	-	-	-	0.02
Other Receivables	4.46	2.41	5.32	4.45	7.8
Total Trade Receivables	4.46	2.41	5.32	4.45	7.82
Total Current Assets	19.83	53.02	7.2	33.79	29.49
Total Assets	19.83	53.02	7.2	33.79	29.49
Accounts Payable	5.39	2.38	1.7	6.81	6.75
Accrued Expenses	1.31	2.4	3.26	4	2.41
Other Current Liabilities	1.37	0.03	0.13	0.18	0.1
Total Current Liabilities	8.07	4.81	5.09	11	9.25
Total Liabilities	8.07	4.81	5.09	11	9.25
Common Stock	5.87	5.87	1.27	1.06	0.7
Retained Earnings	5.89	42.34	0.85	21.73	19.53
Shareholders' Equity	11.76	48.21	2.12	22.79	20.23
Total Liabilities & Equity	19.83	53.02	7.2	33.79	29.49
Net Cash (Debt)	15.37	50.61	1.88	29.34	21.67
Net Cash Growth	-69.64%	2587.84%	-93.58%	35.44%	3578.27%
Net Cash Per Share	6.54	21.54	4.19	94.06	77.02
Book Value	11.76	48.21	2.12	22.79	20.23
Book Value Per Share	5.01	20.52	4.71	73.06	71.93
Tangible Book Value	11.76	48.21	2.12	22.79	20.23
Tangible Book Value Per Share	5.01	20.52	4.71	73.06	71.93